Prognostic Factors in Anti-Neuronal Antibody Positive Patients.

Aydin, Çagla; Çelik, Senay Yildiz; Içöz, Sema; Ulusoy, Canan; Gündüz, Tuncay; Demir, Gülsen Akman; Kürtüncü, Murat; Tüzün, Erdem

Aydin, Çagla; Çelik, Senay Yildiz; Içöz, Sema; Ulusoy, Canan; Gündüz, Tuncay; Demir, Gülsen Akman; Kürtüncü, Murat; Tüzün, Erdem.

Afiliación

Aydin Ç; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Çelik SY; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Içöz S; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Ulusoy C; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Gündüz T; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Demir GA; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Kürtüncü M; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Tüzün E; Department of Neurology, Istanbul University, Faculty of Medicine, Istanbul, Turkey.

Noro Psikiyatr Ars ; 55(2): 189-194, 2018.

Article en En | MEDLINE | ID: mdl-30057463

Palabras clave

Paraneoplastic; antibody; cancer; prognosis; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Noro Psikiyatr Ars Año: 2018 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google